Anúncio
Anúncio

PMVP

PMVP logo

PMV Pharmaceuticals, Inc

1.25
USD
Patrocinado
+0.03
+2.87%
31 de dez., 15:58 UTC -5
Encerrado
exchange

Pós-Mercado

1.25

0.00
0.00%

Relatórios de Lucros PMVP

Rácio de surpresa positiva

PMVP separação 12 de 20 últimas estimativas.

60%

Próximo Relatório

Data do Próximo Relatório
02 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.41
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
+2.50%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/
-8.89%

PMV Pharmaceuticals, Inc earnings per share and revenue

On 12 de nov. de 2025, PMVP reported earnings of -0.40 USD per share (EPS) for Q3 25, beating the estimate of -0.41 USD, resulting in a 2.58% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +6.77% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analistas forecast an EPS of -0.41 USD, with revenue projected to reach -- USD, implying an aumentar of 2.50% EPS, and aumentar of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, PMV Pharmaceuticals, Inc reported EPS of -$0.40, beating estimates by 2.58%, and revenue of $0.00, 0% as expectations.
The stock price moved up 6.77%, changed from $1.33 before the earnings release to $1.42 the day after.
The next earning report is scheduled for 02 de mar. de 2026.
Based on 6 analistas, PMV Pharmaceuticals, Inc is expected to report EPS of -$0.41 and revenue of -- for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio